R. Williamson

3.9k total citations · 1 hit paper
60 papers, 3.1k citations indexed

About

R. Williamson is a scholar working on Infectious Diseases, Molecular Medicine and Molecular Biology. According to data from OpenAlex, R. Williamson has authored 60 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 18 papers in Molecular Medicine and 14 papers in Molecular Biology. Recurrent topics in R. Williamson's work include Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Resistance in Bacteria (18 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). R. Williamson is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Resistance in Bacteria (18 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). R. Williamson collaborates with scholars based in France, United Kingdom and United States. R. Williamson's co-authors include Ludwig Gutmann, Alexander Tomasz, S. Al-Obeid, David M. Shlaes, J. H. Shlaes, Christine Miaskowski, Sunil Panchal, Tsveta Milanova, S. Bolge and Timothy Bell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Clinical Infectious Diseases.

In The Last Decade

R. Williamson

60 papers receiving 2.9k citations

Hit Papers

The Prevalence, Severity, and Impact of Opioid-Induced Bo... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Williamson France 28 826 809 650 572 433 60 3.1k
Gülşen Hasçelik Türkiye 27 608 0.7× 527 0.7× 413 0.6× 355 0.6× 165 0.4× 165 2.6k
Paul Noone United Kingdom 22 599 0.7× 453 0.6× 216 0.3× 277 0.5× 122 0.3× 71 1.9k
Alban Le Monnier France 35 1.0k 1.2× 442 0.5× 845 1.3× 377 0.7× 66 0.2× 213 4.8k
Akiko Nakamura Japan 29 445 0.5× 592 0.7× 767 1.2× 120 0.2× 172 0.4× 141 3.0k
Ralph A. Giannella United States 44 2.0k 2.4× 816 1.0× 1.6k 2.5× 263 0.5× 551 1.3× 121 6.4k
Wolfgang Graninger Austria 30 802 1.0× 484 0.6× 405 0.6× 98 0.2× 79 0.2× 105 2.8k
V. I. Mathan India 35 932 1.1× 623 0.8× 546 0.8× 57 0.1× 275 0.6× 109 3.1k
Kazuhiko Nakajima Japan 25 563 0.7× 374 0.5× 282 0.4× 77 0.1× 58 0.1× 89 2.1k
Olga Zaborina United States 33 590 0.7× 1.1k 1.3× 1.8k 2.7× 308 0.5× 160 0.4× 72 3.5k
John K. Crane United States 27 629 0.8× 264 0.3× 617 0.9× 180 0.3× 46 0.1× 67 2.1k

Countries citing papers authored by R. Williamson

Since Specialization
Citations

This map shows the geographic impact of R. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Williamson more than expected).

Fields of papers citing papers by R. Williamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Williamson. The network helps show where R. Williamson may publish in the future.

Co-authorship network of co-authors of R. Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of R. Williamson. A scholar is included among the top collaborators of R. Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Williamson. R. Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2020). Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study. The Lancet Rheumatology. 2(11). e677–e688. 24 indexed citations
2.
Gungabissoon, Usha, Kimberley Hacquoil, Chanchal Bains, et al.. (2014). Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness. Journal of Parenteral and Enteral Nutrition. 39(4). 441–448. 179 indexed citations
3.
Büchler, Markus W., J. R. T. Monson, Y Flamant, et al.. (2008). Clinical trial: alvimopan for the management of post‐operative ileus after abdominal surgery: results of an international randomized, double‐blind, multicentre, placebo‐controlled clinical study. Alimentary Pharmacology & Therapeutics. 28(3). 312–325. 109 indexed citations
4.
Bell, Timothy, Sunil Panchal, Christine Miaskowski, et al.. (2008). The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1). Pain Medicine. 10(1). 35–42. 410 indexed citations breakdown →
5.
Kehlet, Henrik, Markus W. Büchler, Robert W. Beart, Richard P. Billingham, & R. Williamson. (2005). Care after Colonic Operation—Is it Evidence-Based? Results from a Multinational Survey in Europe and the United States. Journal of the American College of Surgeons. 202(1). 45–54. 201 indexed citations
6.
Kehlet, Henrik, R. Williamson, Markus W. Büchler, & Robert W. Beart. (2005). A survey of perceptions and attitudes among European surgeons towards the clinical impact and management of postoperative ileus. Colorectal Disease. 7(3). 245–250. 38 indexed citations
7.
Mégraud, Françis, et al.. (2000). Ranitidine Bismuth Citrate Can Help to Overcome Helicobacter pylori Resistance to Clarithromycin In Vivo. Helicobacter. 5(4). 222–226. 25 indexed citations
8.
Marini, Robert P., James G. Fox, Nancy S. Taylor, et al.. (1999). Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. American Journal of Veterinary Research. 60(10). 1280–1280. 7 indexed citations
9.
Williamson, R., et al.. (1998). One‐week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Alimentary Pharmacology & Therapeutics. 12(9). 823–837. 75 indexed citations
10.
Williamson, R., et al.. (1997). Approaches to the Prevention and Treatment of Helicobacter pylori infection. The Yale Journal of Biology and Medicine. 70(1). 7–18. 1 indexed citations
11.
McLaren, Alistair S., et al.. (1997). The Role of Ranitidine Bismuth Citrate in Significantly Reducing the Emergence of Helicobacter pylori Strains Resistant to Antibiotics. Helicobacter. 2(1). 21–26. 26 indexed citations
12.
Dixon, Jonathan S., et al.. (1997). Clarithromycin Dual Therapy Regimens for Eradication ofHelicobacter pylori: A Review. Helicobacter. 2(4). 159–171. 21 indexed citations
13.
Al-Obeid, S., Laurent Gutmann, & R. Williamson. (1990). Modification of penicillin-binding proteins of penicillin-resistant mutants of different species of enterococci. Journal of Antimicrobial Chemotherapy. 26(5). 613–618. 27 indexed citations
14.
Shlaes, David M., S. Al-Obeid, J. H. Shlaes, & R. Williamson. (1989). Activity of Various Glycopeptides Against an Inducibly Vancomycin-Resistant Strain of Enterococcus faecium (D366). The Journal of Infectious Diseases. 159(6). 1132–1135. 11 indexed citations
15.
Williamson, R., S. Al-Obeid, J. H. Shlaes, F. W. Goldstein, & David M. Shlaes. (1989). Inducible Resistance to Vancomycin in Enterococcus faecium D366. The Journal of Infectious Diseases. 159(6). 1095–1104. 130 indexed citations
16.
Dang, Pham My‐Chan, Ludwig Gutmann, Claudine Quentin, R. Williamson, & E. Collatz. (1988). Some Properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with Non-Enzyme-Dependent Multiple Resistance to  -Lactam Antibiotics, Aminoglycosides, and Quinolones. Clinical Infectious Diseases. 10(4). 899–904. 11 indexed citations
17.
Williamson, R., E. Collatz, & Ludwig Gutmann. (1986). [Mechanisms of action of beta-lactam antibiotics and mechanisms of non-enzymatic resistance].. PubMed. 15(46). 2282–9. 13 indexed citations
18.
Williamson, R., Ludwig Gutmann, T Horaud, F Delbos, & J. F. Acar. (1986). Use of Penicillin-binding Proteins for the Identification of Enterococci. Microbiology. 132(7). 1929–1937. 48 indexed citations
19.
Williamson, R. & Alexander Tomasz. (1984). Synthesis of penicillin-binding proteins in penicillin-treatedStreptococcus pneumoniae. FEMS Microbiology Letters. 22(3). 301–305. 8 indexed citations
20.
Barlow, J.J., A. P. Mathias, R. Williamson, & D.B. Gammack. (1963). A simple method for the quantitative isolation of undegraded high molecular weight ribonucleic acid. Biochemical and Biophysical Research Communications. 13(1). 61–66. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026